Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05259410 · ClinicalTrials.gov registry record · NA
Time Restricted Eating During Chemotherapy for Breast Cancer
A NA study of Breast Cancer Female, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05259410: Recruiting NA study of Breast Cancer Female, sponsored by University of Illinois at Chicago.
NCT05259410 is a NA study of Breast Cancer Female that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 40 participants, below the 692-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05259410, a NA study of Breast Cancer Female, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Breast cancer is the most common cancer in the United States however, little is known about how diet can affect cancer treatment. Pre-clinical murine studies report intermittent fasting increases effectiveness of chemotherapy and decreases treatment related adverse events. The proposed research will demonstrate that time restricted eating, a form of intermittent fasting, will improve treatment related outcomes, patient related outcomes, and limit treatment related weight gain and fat mass accretion.Time restricted eating combined with a mediterranean diet will also be feasible and improve cardiometabolic risk more than TRE alone or standard care.
Primary Outcome
enrollment rate
Conditions Studied
Interventions
- BEHAVIORAL TRE
- BEHAVIORAL MedTRE
Study Locations (1)
Illinois
- University of Illinois Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
What NCT05259410 shows while recruiting
NCT05259410 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 692-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Breast Cancer Female appearing as the primary indexed condition, and to 2 interventions - of which TRE is the first listed.
NCT05259410 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05259410 about?
NCT05259410 is a clinical study titled "Time Restricted Eating During Chemotherapy for Breast Cancer". Breast cancer is the most common cancer in the United States however, little is known about how diet can affect cancer treatment. Pre-clinical murine studies report intermittent fasting increases effectiveness of chemotherapy and decreases treatment related adverse events. The proposed research will...
What is the current status of trial NCT05259410?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-08-01. Estimated completion is 2026-03-01.
What conditions does trial NCT05259410 study?
This clinical trial studies the following conditions: Breast Cancer Female.
What interventions are being tested in trial NCT05259410?
The interventions under investigation include: TRE (BEHAVIORAL), MedTRE (BEHAVIORAL).
Who is sponsoring clinical trial NCT05259410?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05259410 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05259410's enrollment target sits among peer trials
40 36th of 46 higher than 11 of 46 other Breast Cancer Female trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer Female trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Breast Cancer Resiliency Through Exercise Program (B-REP)
RECRUITING · NA
-
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
RECRUITING · NA
-
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
RECRUITING · NA
-
Cognitive Rehabilitation Following Breast Cancer Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI